GeneTex

  • Country / Location Selection

United States (US)

Cav3.2 blocking peptide

Cat. No. GTX31939-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all Cav3.2 products
PRODUCT

Summary

Cav3.2 peptide is used for blocking the activity of Cav3.2 antibody (catalog number GTX31939).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Calcium Voltage-Gated Channel Subunit Alpha1 H , Cacna1Hb , Cav3.2 , Eca6 , Eig6 , Hald4 , Cacna1H

Background

This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for Cav3.2 blocking peptide (GTX31939-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for Cav3.2 blocking peptide (GTX31939-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139